189 related articles for article (PubMed ID: 36263180)
21. TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.
Yan X; Zhang J; Pan L; Wang P; Xue H; Zhang L; Gao X; Zhao X; Ning Y; Chen YG
Mol Cell Biol; 2011 Sep; 31(18):3700-9. PubMed ID: 21791611
[TBL] [Abstract][Full Text] [Related]
22. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
[TBL] [Abstract][Full Text] [Related]
24. HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction.
Zhu C; Piao Z; Jin L
Orphanet J Rare Dis; 2023 Sep; 18(1):266. PubMed ID: 37667300
[TBL] [Abstract][Full Text] [Related]
25. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
26. Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children.
Zhang Z; Finnerty CC; He J; Herndon DN
Burns; 2012 Mar; 38(2):236-46. PubMed ID: 21920670
[TBL] [Abstract][Full Text] [Related]
27. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
Li Y; Yu Z; Zhao D; Han D
Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
[TBL] [Abstract][Full Text] [Related]
28. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
[TBL] [Abstract][Full Text] [Related]
29. Lnc-Ang362 is a pro-fibrotic long non-coding RNA promoting cardiac fibrosis after myocardial infarction by suppressing Smad7.
Chen G; Huang S; Song F; Zhou Y; He X
Arch Biochem Biophys; 2020 May; 685():108354. PubMed ID: 32240638
[TBL] [Abstract][Full Text] [Related]
30. Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo.
Luwor RB; Baradaran B; Taylor LE; Iaria J; Nheu TV; Amiry N; Hovens CM; Wang B; Kaye AH; Zhu HJ
Oncogene; 2013 May; 32(19):2433-41. PubMed ID: 22751114
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.
Xiong C; Guan Y; Zhou X; Liu L; Zhuang MA; Zhang W; Zhang Y; Masucci MV; Bayliss G; Zhao TC; Zhuang S
FASEB J; 2019 Jul; 33(7):8249-8262. PubMed ID: 30951378
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
[TBL] [Abstract][Full Text] [Related]
33. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
[No Abstract] [Full Text] [Related]
35. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
[TBL] [Abstract][Full Text] [Related]
36. Aberrant miR-21 and miR-200b expression and its pro-fibrotic potential in hypertrophic scars.
Zhou R; Zhang Q; Zhang Y; Fu S; Wang C
Exp Cell Res; 2015 Dec; 339(2):360-6. PubMed ID: 26500110
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization of TRAP1-like protein involved in modulating fibrotic processes mediated by TGF-β/Smad signaling in hypertrophic scar fibroblasts.
Wang X; Chu J; Wen CJ; Fu SB; Qian YL; Wo Y; Wang C; Wang DR
Exp Cell Res; 2015 Mar; 332(2):202-11. PubMed ID: 25655281
[TBL] [Abstract][Full Text] [Related]
39. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
40. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.
Li JH; Zhu HJ; Huang XR; Lai KN; Johnson RJ; Lan HY
J Am Soc Nephrol; 2002 Jun; 13(6):1464-72. PubMed ID: 12039975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
